An open study to compare the efficacy of immunoglobulin administered subcutaneoulsy (SCIG) with current best practice in patients with Complex Regional Pain Syndrome (CRPS)

Registry ID

EUCTR2009-015242-30

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE4

Sponsor

The Walton Centre for Neurology and Neurosurgery NHS Trust

Start date

2009-11-05

Completion date

2011-11-07

Last update

2026-08-16

Conditions

• Complex Regional Pain Syndrome (CRPS)

Summary

To ascertain the efficacy of repeated doses over one year of immune modulation treatment with a subcutaneous preparation of immunoglobulins (SCIG) in patients who had pain relief after a single dose intravenous immunoglobulin treatment.

Locations

• , , UK

Related clinical trials

• Effectiveness of Transcranial Direct Current Stimulation (tDCS) in the Management of Complex Regional Pain Syndrome
• Peripersonal Space Representation in Upper Limb Segmental Exclusion

View on source registry